Doyle Mittie
Avalo Therapeutics, Inc. · Chief Medical Officer
Doyle Mittie is listed in public filings as officer: Chief Medical Officer. This Doyle Mittie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Avalo Therapeutics, Inc. (AVTX), and Cullinan Therapeutics, Inc. (CGEM). Investors use Doyle Mittie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $56k3k shares | SellMay 15, 2026 | $18.76 | -- | |
| $953k44.9k shares | SellMay 6, 2026 | $21.20 | -- | |
| $496k27.5k shares | SellMay 6, 2026 | $18.03 | -- | |
| $426k19k shares | SellMay 6, 2026 | $22.41 | -- | |
| $230k10.1k shares | SellMay 6, 2026 | $22.88 | -- | |
| $98k5k shares | SellMay 6, 2026 | $19.65 | -- | |
| $27k1.7k shares | SellMay 5, 2026 | $16.00 | -- | |
| $72k4k shares | SellApr 6, 2026 | $18.01 | -- | |
| $11k679 shares | SellApr 1, 2026 | $16.00 | -- | |
| $412k25.5k shares | SellMar 16, 2026 | $16.15 | -- |